RESEARCH
The Institute for Biomedical Sciences promotes interdisciplinary research that drives advances in the biomedical sciences through synergistic collaboration, ultimately leading to better patient care. Our researchers are focused on understanding the mechanistic basis for a variety of important human diseases, such as inflammatory, immunologic and infectious diseases, and developing innovative approaches to prevention, diagnosis and treatment.
Six lead researchers in the Institute for Biomedical Sciences are developing therapeutics and vaccines to fight COVID-19.
Areas of Research
- Immunology (molecular and cellular immunology, inflammation, immunity, chemical immunology, tumor immunology, systems and computational immunology)
- Translational immunology
- Microbiology (molecular and cellular microbiology, host-pathogen interactions, microbiota, translational microbiology, systems and computational microbiology)
- Microbial pathogenesis
- Infectious diseases (COVID-19, Ebola, influenza, respiratory syncytial virus, measles, sexually transmitted infections, HIV, streptococcus pneumoniae)
- Inflammatory diseases (inflammatory bowel disease, chronic obstructive pulmonary disease, otitis media, autoimmune diseases)
- Cardiovascular diseases, diabetes and metabolic disorders
Molecular and cellular medicine - Translational cancer biology
- Translational medicine
- Translational systems biology and bioinformatics
- Vaccinology (flu, RSV, HIV, gonorrhea)
- Diagnostics and biomarkers
- Therapeutics and nanomedicine
